Our portfolio includes nucleic acid detection for pathogens such as HIV, HBV, and tuberculosis, as well as technologies for exosome isolation, nucleic acid extraction and purification, and dried blood spot (DBS) collection cards, together with supporting reagents and consumables. Through continuous technological innovation, we deliver reliable and efficient testing solutions for public health systems, healthcare institutions, and reference laboratories. These technologies support the full clinical pathway, from early screening and precise diagnosis to treatment monitoring and cure assessment.